1. Home
  2. NRSN vs CENN Comparison

NRSN vs CENN Comparison

Compare NRSN & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • CENN
  • Stock Information
  • Founded
  • NRSN 2017
  • CENN 2013
  • Country
  • NRSN Israel
  • CENN United States
  • Employees
  • NRSN N/A
  • CENN N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • NRSN Health Care
  • CENN Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • CENN Nasdaq
  • Market Cap
  • NRSN 26.0M
  • CENN 28.3M
  • IPO Year
  • NRSN 2021
  • CENN N/A
  • Fundamental
  • Price
  • NRSN $0.91
  • CENN $0.84
  • Analyst Decision
  • NRSN Hold
  • CENN
  • Analyst Count
  • NRSN 1
  • CENN 0
  • Target Price
  • NRSN N/A
  • CENN N/A
  • AVG Volume (30 Days)
  • NRSN 172.3K
  • CENN 186.0K
  • Earning Date
  • NRSN 04-08-2025
  • CENN 05-11-2025
  • Dividend Yield
  • NRSN N/A
  • CENN N/A
  • EPS Growth
  • NRSN N/A
  • CENN N/A
  • EPS
  • NRSN N/A
  • CENN N/A
  • Revenue
  • NRSN N/A
  • CENN $37,052,841.00
  • Revenue This Year
  • NRSN N/A
  • CENN N/A
  • Revenue Next Year
  • NRSN N/A
  • CENN N/A
  • P/E Ratio
  • NRSN N/A
  • CENN N/A
  • Revenue Growth
  • NRSN N/A
  • CENN 142.48
  • 52 Week Low
  • NRSN $0.51
  • CENN $0.64
  • 52 Week High
  • NRSN $2.25
  • CENN $2.30
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 38.31
  • CENN 41.49
  • Support Level
  • NRSN $1.00
  • CENN $0.86
  • Resistance Level
  • NRSN $1.13
  • CENN $0.98
  • Average True Range (ATR)
  • NRSN 0.08
  • CENN 0.07
  • MACD
  • NRSN -0.02
  • CENN -0.01
  • Stochastic Oscillator
  • NRSN 28.23
  • CENN 3.05

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.

Share on Social Networks: